Case Study: Obsidian Therapeutics achieves unified R&D informatics and secure traceability with Benchling

Unlocking Pivotal R&D Answers While Ensuring Data Integrity

Obsidian Therapeutics, which develops technologies to control protein activity for therapeutic use, faced fragmented informatics: a clunky ELN that couldn’t link to registered samples, no formal registration system to connect results with upstream entities, and an unintuitive sample-tracking tool that saw low scientist adoption, data loss, and compliance risk.

By adopting Benchling’s integrated ELN, sample tracking, and Bioregistry, Obsidian centralized registration and linked experimental records to upstream constructs and batches. The solution drove strong scientist adoption, improved the quality and reliability of experimental records, enabled traceability from results to specific entities (e.g., why a lentivirus performs well), and provided secure, legally defensible tracking of constructs and parts.

Obsidian Therapeutics